Discover 2,576 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,576
Active & Responsive
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Tumor,
Location: New York NY, Hampton VA, Baltimore MD, Fairfax VA,
Sponsor: Proton Collaborative Group
Sex: Female
Age: 50+
Code: NCT01766297
Phase2, Recruiting
Active & Responsive
Communication Bridge 3 Study
for
Primary Progressive Aphasia
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18 - 70+
Code: NCT06191198
Phase2, Recruiting
Active & Responsive
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Maywood IL, Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT03824145
Recruiting
Active & Responsive
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Location: Boston MA, Cincinnati OH, Nashville TN, Chicago IL,
Sponsor: Fresenius Kabi
Sex: All
Age: 0 - 17
Code: NCT06274788
Recruiting
Active & Responsive
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Hershey PA, Coral Gables FL, Tampa FL, Ann Arbor MI,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Sex: All
Age: 0 - 70+
Code: NCT05500807
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
for
Acute Myeloid Leukemia, Relapsed, Adult,
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18 - 65
Code: NCT06802315
Phase2, Recruiting
Active & Responsive
Alcohol After Bariatric Surgery 2
for
Sleeve Gastrectomy
Location: Urbana IL
Sponsor: University of Illinois at Urbana-Champaign
Sex: All
Age: 21 - 64
Code: NCT06257771
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Augusta ME, Boston MA, Providence RI, Concord NH,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
for
Scoliosis Idiopathic
Location: New York NY, Philadelphia PA, Washington DC, Ottawa,
Sponsor: Pediatric Spine Foundation
Sex: All
Age: 0 - 18
Code: NCT04914507
Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Lebanon NH, Mineola NY, New York NY, Hackensack NJ,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase1, Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Boston MA, New Haven CT, West Haven CT, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
for
Hydrocephalus
Location: Chicago IL
Sponsor: Rhaeos, Inc.
Sex: All
Age: 6 - 70+
Code: NCT06996600
Recruiting
Active & Responsive
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
for
Pressure Ulcer, Stage IV, Osteomyelitis
Location: Mineola NY, Newark NJ, Pittsburgh PA, Detroit MI,
Sponsor: Biocomposites Ltd
Sex: All
Age: 18+
Code: NCT06283979
Phase2, Recruiting
Active & Responsive
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Location: Winston-Salem NC, Bradenton FL, O'Fallon IL,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06538064
Recruiting
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
Location: Pennington NJ, Philadelphia PA, Newark DE, Baltimore MD,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Active & Responsive
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: New York NY, Philadelphia PA, Bethesda MD,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3+
Code: NCT02523118
Recruiting
Active & Responsive
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
for
Leg Ulcer
Location: Boston MA, Providence RI, Chapel Hill NC, Tamarac FL,
Sponsor: Intercytex
Sex: All
Age: 18+
Code: NCT00232973
Phase3, Recruiting
New
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
for
Ependymoma, High Grade Gliomas
Location: Chicago IL
Sponsor: Cerenome
Sex: All
Age: 6 - 21
Code: NCT07061626
Phase1, Recruiting
New
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
for
Congenital Adrenal Hyperplasia
Location: Hartford CT, Atlanta GA, Ann Arbor MI, Indianapolis IN,